Stay updated on Etripamil Nasal Spray Safety Study Clinical Trial
Sign up to get notified when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.

Latest updates to the Etripamil Nasal Spray Safety Study Clinical Trial page
- Check5 days agoChange DetectedAdded a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check12 days agoChange DetectedUI and metadata updates include adding a Show glossary option, adding Last Update Submitted that Met QC Criteria, standardizing 'No FEAR Act Data' capitalization, and updating the revision label to v3.4.0.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to study content or page data.SummaryDifference0.0%

- Check47 days agoChange DetectedAdded a comprehensive locations section (including US states and international sites such as Buenos Aires, REG1, British Columbia, Ontario, and Quebec) and updated the revision to v3.3.3, while removing the previous v3.3.2 location blocks.SummaryDifference2%

- Check61 days agoChange DetectedAdded a publication entry for Ip JE et al. (2025) in the Publications section and removed the prior 'Online ahead of print' listing for the same article.SummaryDifference0.0%

- Check75 days agoChange DetectedMinor wording change in the Publications note to indicate publications are automatically filled from PubMed and may not be about the study, and the page revision indicator updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Etripamil Nasal Spray Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etripamil Nasal Spray Safety Study Clinical Trial page.